Sains Malaysiana 53(3)(2024): 681-689

http://doi.org/10.17576/jsm-2024-5303-15

Investigation of Phosphorylated and O-Glycosylated Proteins in Gestational Diabetes Mellitus

(Penelitian Protein Terfosforilasi dan Terglikosilasi O dalam Kehamilan Diabetes Mellitus)

AFSHAN KALEEM*, TEHREEM ANWAR, AQSA IFTIKHAR, ROHEENA ABDULLAH, MEHWISH IQTEDAR & MAHWISH AFTAB

Department of Biotechnology, Lahore College for Women University, Lahore-54000, Pakistan

Diserahkan: 17 Ogos 2023/Diterima: 21 Februari 2024

Abstract

Gestational Diabetes Mellitus (GDM) is a common but temporary type of diabetes that develops among 10-20% of all pregnant women. It is a major cause of several pre- and post-pregnancy diseases in both mother and offspring. The main causative is altered pregnancy hormones that lead to deficient glucose metabolism. Complications can be preeclampsia, caesarean sections and cardiovascular diseases. This study was designed to determine the phosphorylated and glycosylated proteins present in GDM and to investigate the role of their post-translational modifications (PTMs) in the pathogenesis of GDM. The study was performed on 30 blood samples from pregnant diabetic women (diseased), 30 pregnant non-diabetic women (control) and 30 women without pregnancy and gestational diabetes (normal). Protein extraction was done from blood plasma, and phosphorylated and glycosylated proteins were determined by Enzyme-Linked Immuno-Sorbent Assay (ELISA) by use of specific antibodies. This study showed that proteins found in GDM are highly phosphorylated and O-glycosylated (p<0.01). Furthermore, a bioinformatic investigation was done, which showed that blood coagulation proteins such as the Fibrinogen alpha chain and lipid metabolism-regulating proteins apolipoprotein E, L1 and C-III showed a high potential for phosphorylation, which suggests that phosphorylation can be used as a therapeutic marker in GDM.

Keywords: Gestational diabetes mellitus; glycosylation; phosphorylation; protein modification

Abstrak

Kehamilan Diabetes Mellitus (GDM) adalah jenis diabetes biasa tetapi sementara yang berlaku dalam kalangan 10-20% daripada semua wanita hamil. Ia adalah punca utama kepada beberapa penyakit sebelum dan selepas kehamilan pada ibu dan anak. Penyebab utama adalah perubahan hormon kehamilan yang membawa kepada kekurangan metabolisme glukosa. Komplikasi boleh menjadi preeklampsia, pembedahan caesarean dan penyakit kardiovaskular. Kajian ini direka bentuk untuk menentukan protein terfosforilasi dan terglikosilasi yang hadir dalam GDM dan untuk mengkaji peranan pengubahsuaian pasca translasi (PTM) mereka dalam patogenesis GDM. Kajian dilakukan terhadap 30 sampel darah daripada wanita hamil yang menghidap diabetes (berpenyakit), 30 wanita hamil bukan kencing manis (kawalan) dan 30 wanita tidak hamil dan tiada kencing manis (normal). Pengekstrakan protein dilakukan daripada plasma darah dan protein terfosforilasi dan glikosilasi ditentukan oleh Asai Imunosorben Berkait Enzim (ELISA) dengan menggunakan antibodi khusus. Kajian ini menunjukkan bahawa protein yang terdapat dalam GDM adalah sangat terfosforilasi dan O-glikosilasi (p<0.01). Tambahan pula, penyelidikan bioinformatik telah dilakukan yang menunjukkan bahawa protein pembekuan darah seperti rantai alfa Fibrinogen dan protein yang mengawal metabolisme lipid apolipoprotein E, L1 dan C-III menunjukkan potensi tinggi untuk fosforilasi yang mencadangkan bahawa fosforilasi boleh digunakan sebagai penanda terapeutik dalam GDM.

Kata kunci: Kehamilan Diabetes Mellitus; pengubahsuaian protein; glikosilasi; fosforilasi

RUJUKAN

American Diabetes Association (ADA). 2019. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2019. Diabetes Care 42(1): S13-S28.

Ardito, F., Giuliani, M., Perrone, D., Troiano, G. & Muzio, L. 2017. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy. International Journal of Molecular Medicine 40(2): 271-280.

Badakhsh, M., Daneshi, F., Abavisani, M., Rafiemanesh, H., Bouya, S., Sheyback, M. & Balouchi, A. 2019. Prevalence of gestational diabetes mellitus in Eastern Mediterranean region: A systematic review and meta-analysis. Endocrine 65: 505-514.

Blom, N., Gammeltoft, S. & Brunak, S. 1999. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. Journal of Molecular Biology 294(5): 1351-1362.

Butkinaree, C., Park, K. & Hart, G.W. 2010. O-linked β-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochimica et Biophysica Acta (BBA)-General Subjects 1800(2): 96-106.

Chen, M., Shi, J.L., Zheng, Z.M., Lin, Z., Li, M.Q. & Shao, J. 2022. Galectins: Important regulators in normal and pathologic pregnancies. International Journal of Molecular Sciences 23(17): 10110.

Chu, Y.L., Gong, Y.D., Su, Z.H., Yu, H.N., Cui, Q., Jiang, H.Y. & Qu, H.M. 2014. Relationship between tyrosine phosphorylation and protein expression of insulin receptor and insulin resistance in gestational diabetes mellitus. Journal of Huazhong University of Science and Technology 34(3): 393-397.

de Vries, J.J., Snoek, C.J.M., Rijken, D.C. & de Maat, M.P.M. 2020. Effects of post-translational modifications of fibrinogen on clot formation, clot structure, and fibrinolysis: A systematic review. Arteriosclerosis Thrombosis and Vascular Biology 40: 554-569.

Feng, H., Su, R., Song, Y., Wang, C., Lin, L., Ma, J. & Yang, H. 2016. Positive correlation between enhanced expression of TLR4/MyD88/NF-κB with insulin resistance in placentae of gestational diabetes mellitus. PLoS ONE 11(6): e0157185.

Gorar, S., Alioglu, B., Ademoglu, E., Uyar, S., Bekdemir, H., Candan, Z. & Aral, Y. 2016. Is there a tendency for thrombosis in gestational diabetes mellitus? Journal of Laboratory Physicians 8(2): 101-105.

Gual, P., Le Marchand-Brustel, Y. & Tanti, J-F. 2005. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87(1): 99-109.

Jaskolka, D., Retnakaran, R., Zinman, B. & Kramer, C.K. 2015. Sex of the baby and risk of gestational diabetes mellitus in the mother: A systematic review and meta-analysis. Diabetologia 58: 2469-2475.

Kaleem, A., Javed, S., Rehman, N., Abdullah, R., Iqtedar, M., Aftab, M.N. & Haq, I.U. 2021. Phosphorylated and O-GlcNAc modified IRS-1 (Ser1101) and -2 (Ser1149) contribute to human diabetes type II. Protein Peptide Letters 28(3): 333-339.

Kim, S.M., Park, J.S., Norwitz, E.R., Lee, S.M., Kim, B.J., Park, C.W. & Syn, H.C. 2012. Identification of proteomic biomarkers in maternal plasma in the early second trimester that predict the subsequent development of gestational diabetes. Reproductive Sciences 19: 202-209.

Lapolla, A. & Traldi, P. 2022. Proteomic approaches in the study of placenta of pregnancy complicated by gestational diabetes mellitus. Biomedicines 10(9): 2272.

Li, J., Lu, L., Xie, X., Dai, X., Zheng, S. & Chen, L. 2021. Proteomics analysis of serum proteins in gestational diabetes. Evidence-Based Complementary and Alternative Medicine 2(2021): 4724590.

Ma, J. & Hart, G.W. 2013. Protein O-GlcNAcylation in diabetes and diabetic complications. Expert Review of Proteomics 10(4): 365-380.

Mahjabeen, S., Selim, S., Mustari, M., Rajib, M.H., Rahman, A.K.M.S., Fariduddin, M. & Hasanat, M.A. 2022. Association of plasma fibrinogen and insulin resistance in women with gestational diabetes mellitus. Archives of Clinical and Biomedical Research 6: 492-502.

Mielczarek‑Palacz, A., Kondera‑Anasz, Z., Smycz‑Kubańska, M., Englisz, A., Janusz, A., Królewska‑Daszczyńska, P. & Wendlocha, D. 2022. The role of galectins‑1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer. Molecular Medicine Reports 25: 166.

Nagel, A.K. & Ball, L.E. 2014. O-GlcNAc transferase and O-GlcNAcase: Achieving target substrate specificity. Amino Acids 46(10): 2305-2316.

Nguyen, C.L., Pham, N.M., Binns, C.W., Duong, D.V. & Lee, A.H. 2018. Prevalence of gestational diabetes mellitus in eastern and southeastern Asia: A systematic review and meta-analysis. Journal of Diabetes Research 2018: 6536974.

Ning, J. & Yang, H. 2021. O-GlcNAcylation in hyperglycemic pregnancies: Impact on placental function. Frontiers in Endocrinology 12: 659733.

Plows, J.F., Stanley, J.L., Baker, P.N., Reynolds, C.M. & Vickers, M.H. 2018. The pathophysiology of gestational diabetes mellitus. International Journal of Molecular Sciences 19(11): 3342.

Qu, H.M., Ye, Y.H., Peng, W. & Zhan, Y. 2007. Relationship between tyrosine phosphorylation and protein expression of insulin receptor substrate-1 and insulin resistance in gestational diabetes mellitus. Zhonghua Fu Chan Ke Za Zhi 42(4): 249-252.

Ramanjaneya, M., Butler, A.E., Bashir, M., Bettahi, I., Moin, A.S.M., Ahmed, L. & Abou-Samra, A.B. 2021. ApoA2 correlates to gestational age with decreased apolipoproteins A2, C1, C3 and E in gestational diabetes. BMJ Open Diabetes Research and Care 9(1): e001925.

Saltiel, A.R. & Kahn, C.R. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414(6865): 799-806.

Semba, R.D., Huang, H., Lutty, G.A., Van Eyk, J.E. & Hart, G.W. 2014. The role of O‐GlcNAc signaling in the pathogenesis of diabetic retinopathy. PROTEOMICS-Clinical Applications 8(3-4): 218-231.

Sevillano, J., de Castro, J., Bocos, C., Herrera, E. & Ramos, M.P. 2007. Role of insulin receptor substrate-1 serine 307 phosphorylation and adiponectin in adipose tissue insulin resistance in late pregnancy. Endocrinology 148: 5933-5942.

Teliga-Czajkowska, J., Sienko, J., Zareba-Szczudlik, J., Malinowska-Polubiec, A., Romejko-Wolniewicz, E. & Czajkowski, K. 2019. Influence of glycemic control on coagulation and lipid metabolism in pregnancies complicated by pregestational and gestational diabetes mellitus. Advances in Experimental Medicine Biology 1176: 81-88.

Weber, D., Milkovic, L., Bennett, S.J., Griffiths, H.R., Zarkovic, N. & Grune, T. 2013. Measurement of HNE-protein adducts in human plasma and serum by ELISA - Comparison of two primary antibodies. Redox Biology 1(1): 226-233.

Whelan, S.A., Dias, W.B., Thiruneelakantapillai, L., Lane, M.D. & Hart, G.W. 2010. Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-linked β-N-acetylglucosamine in 3T3-L1 adipocytes. Journal of Biological Chemistry 285(8): 5204-5211.

Xu, X., Liu, Y., Liu, D., Li, X., Rao, Y., Sharma, M. & Zhao, Y. 2017. Prevalence and determinants of gestational diabetes mellitus: A cross-sectional study in China. International Journal of Environmental Research and Public Health 14(12): 1532.

Yang, X. & Qian, K. 2017. Protein O-GlcNAcylation: Emerging mechanisms and functions. Nature Reviews Molecular Cell Biology 18(7): 452.

Zhang, Y., Zhang, Y., Ding, G.L., Liu, X.M., Ye, J., Sheng, J.Z. & Huang, H.F. 2017. Regulation of hepatic pyruvate dehydrogenase phosphorylation in offspring glucose intolerance induced by intrauterine hyperglycemia. Oncotarget 8(9): 15205-15212.

*Pengarang untuk surat-menyurat; email: afshan.kaleem@lcwu.edu.pk